Zobrazeno 1 - 10
of 38
pro vyhledávání: '"J. J. Zarba"'
Publikováno v:
Journal of Clinical Oncology. 39:e13049-e13049
e13049 Background: Breast cancer (BC) is the most prevalent tumor in women and the leading cause of cancer death in women. TNBC has the worst prognosis among BC subtypes and limited treatment options, mainly including chemotherapy. The efficacy of im
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b81e4c0f2e2a2f052009ca17902578e1
https://doi.org/10.1200/jco.2021.39.15_suppl.e13049
https://doi.org/10.1200/jco.2021.39.15_suppl.e13049
Autor:
Italia Vega, William Tsutomu Watanabe, Natalia Bliss, Adriana Beatriz Gonzalez, S. Holgado, Daniel Gustavo Goroso, J. J. Zarba, Ana Vinuales
Publikováno v:
Journal of Clinical Oncology. 39:e13535-e13535
e13535 Background: : UCN is one of the major public health problems in Tucumán, that must be related to the type of population to which it belongs (Rural or Urban). Geolocation allows the processing and analysis of geographic information whose resul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e3875c403161b7f81394cf0366f08d41
https://doi.org/10.1200/jco.2021.39.15_suppl.e13535
https://doi.org/10.1200/jco.2021.39.15_suppl.e13535
Autor:
Celia Tosello, Silvia P. Neciosup, Guillermo Lerzo, Luis Fein, Hélio Pinczowski, Gustavo Werutsky, Carlos H. Barrios, Gustavo Ismael, J. J. Zarba, C. Blajman, Mirta Susana Varela, José Bines, Patrícia X. Santi, Yeni Nerón, Carlos Sampaio, Marcello Fanelli, Adolfo Capó, Max S. Mano, Henry L. Gomez, Jeovany Martínez-Mesa
Publikováno v:
Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP
Universidade de São Paulo (USP)
instacron:USP
Background Novel targeted agents and combinations have become available in multiple lines of treatment for human epidermal growth factor receptor 2-positive (HER2+) metastatic breast cancer (MBC). In this context, alternatives to the lapatinib (L) an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a2eb49abcc7614d4a358430c300f92e6
Autor:
Diego Kaen, Oscar Arrieta, António J. Silva, Andrés F. Cardona, Fernanda A. Oliveira, A. Quiroba, Pamela Salman, G. Borges, A. Gelatti, J. J. Zarba, Carlos Barrios, C. Mathias, Eduardo Cronemberger, L. Fein, Eldsamira Mascarenhas, R. Trejo, H. Andrade, L.H. Araujo, J. Lobaton, J.O. Dias, C. Campos, I. Morbeck, Gustavo Werutsky, Juliano Ce Coelho, V. Cordeiro De Lima, M. Zukin
Publikováno v:
Journal of Thoracic Oncology. 14:S1080-S1081
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::da2de66c806c95b200828991fb255bdf
https://doi.org/10.1016/j.jtho.2019.08.2404
https://doi.org/10.1016/j.jtho.2019.08.2404
Autor:
Henry L. Gomez, Carlos H. Barrios, Jeovany Martínez-Mesa, Alfonso Dueñas-González, Gustavo Werutsky, Max S. Mano, Cynthia Villarreal-Garza, Stefan Michiels, J. J. Zarba, C.A.S. Pereira Filho
Publikováno v:
Public health. 149
To evaluate whether a country's Human Development Index (HDI) can help explain the differences in the country's breast cancer and gynecological cancer incidence and mortality rates in the Pan-American region.Ecological analysis.Pan-American region co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce58a0c50f8f98ac5721acfa7120a743
https://pubmed.ncbi.nlm.nih.gov/28577441
https://pubmed.ncbi.nlm.nih.gov/28577441
Autor:
Conrado Oscar Cinto, Adriana Beatriz Gonzalez, Veronica Ali, Maria Fernanda Arrieta, Claudia Veronica Abete, J. J. Zarba, S. Holgado
Publikováno v:
Journal of Clinical Oncology. 37:e13063-e13063
e13063 Background: The benefits of population screening under the program in women at risk of uterine cervical cancer both methodsof detection, the search of lesions by gynecological cytology or the search for infection by oncogenic virus of the VPH
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5dc68e78a86792fe5f3bf05b5af376a5
https://doi.org/10.1200/jco.2019.37.15_suppl.e13063
https://doi.org/10.1200/jco.2019.37.15_suppl.e13063
Autor:
Cristian Micheri, Luis Fein, Martin Eduardo Richardet, Ezequiel Klimovsky, E. H. Ortiz, Florencia Visintini Jaime, Mirta Susana Varela, Lucas Cordeiro, Andrea Federico, Nestor Lago, Susana Kahl, Ruben Dario Kowalyszyn, Gustavo Cortese, Jorge Horacio Cassini, J. J. Zarba
Publikováno v:
Journal of Clinical Oncology. 37:3113-3113
3113 Background: Peg-Neutropine, GEMA BIOTECH SAU biosimilar Peg-Filgrastim, is the first Peg-Filgrastim approved in LATAM for prevention of febrile neutropenia in patients treated with myelosuppressive chemotherapy. Methods: Study population: women
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a748accc545c018b3725e76b1aca8335
https://doi.org/10.1200/jco.2019.37.15_suppl.3113
https://doi.org/10.1200/jco.2019.37.15_suppl.3113
Autor:
José Bines, Jeovany Martínez-Mesa, C Sampaio, Carlos Barrios, Silvia P. Neciosup, C. Blajman, C Tosello, H Pinczowsky, Varela, A Capo, Gustavo Ismael, Max S. Mano, J. J. Zarba, PX Santi, M Fanelli, Luis Fein, Henry L. Gomez, G. Lerzo, Gustavo Werutsky, Y. Neron
Publikováno v:
Cancer Research. 73:P4-12
Background: Lapatinib-Capecitabine (LC) is approved for the treatment of advanced or metastatic breast cancer (MBC) whose tumors overexpress HER2 and who have received prior therapy including an anthracycline, a taxane (T), and trastuzumab (H). LACOG
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f9d57f6af000eaad438509fb6d9e0057
https://doi.org/10.1158/0008-5472.sabcs13-p4-12-26
https://doi.org/10.1158/0008-5472.sabcs13-p4-12-26
Autor:
Maria V. Caceres, María Soledad Bover, Pablo Capellino, Miriam Gabriela Raimondo, Ana Carolina Ituarte, Diego Kaen, J. J. Zarba, Maria Del Carmen Gramuglia, Sandra Anabel Ostoich, Martin Guillermo Roa, Marcelo Jesus, Jimena Andrea Tejada, Bruno Bustos, Clelia Maria Vico
Publikováno v:
Journal of Clinical Oncology. 36:e17500-e17500
e17500Background: In Argentina, 5000 women are diagnosed every year with cervical cancer and half of them die from the disease. Cisplatin-Paclitaxel + Bevacizumab (TP-B) had improved the survival o...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f4c8a9165378bea225bd634aa2ecf69f
https://doi.org/10.1200/jco.2018.36.15_suppl.e17500
https://doi.org/10.1200/jco.2018.36.15_suppl.e17500
Autor:
Eunsik Lee, Pamela Salman, Lauren McCann, Cora N. Sternberg, Cezary Szczylik, Robert E. Hawkins, Oleg Gladkov, Lini Pandite, Ian D. Davis, John Wagstaff, Mei Chen, Debasish F. Roychowdhury, Jozef Mardiak, Alexander Kavina, Carlos H. Barrios, J. J. Zarba
Publikováno v:
Journal of Clinical Oncology. 28:1061-1068
Purpose Pazopanib is an oral angiogenesis inhibitor targeting vascular endothelial growth factor receptor, platelet-derived growth factor receptor, and c-Kit. This randomized, double-blind, placebo-controlled phase III study evaluated efficacy and sa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf517c9b8de9f9ec3edb88715e137841
https://doi.org/10.1200/jco.2009.23.9764
https://doi.org/10.1200/jco.2009.23.9764